These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 16248867)
1. Combining treprostinil and sildenafil in the treatment of pulmonary hypertension. Chua R; Keogh A Intern Med J; 2005 Nov; 35(11):684-5. PubMed ID: 16248867 [No Abstract] [Full Text] [Related]
2. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension. Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071 [TBL] [Abstract][Full Text] [Related]
3. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results]. Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792 [TBL] [Abstract][Full Text] [Related]
4. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension. Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of sildenafil added to treprostinil in pulmonary hypertension. Gomberg-Maitland M; McLaughlin V; Gulati M; Rich S Am J Cardiol; 2005 Nov; 96(9):1334-6. PubMed ID: 16253609 [TBL] [Abstract][Full Text] [Related]
6. [The combined use of sildenafil with epoprostenol in a patient with primary pulmonary hypertension]. Kayikçioğlu M; Can LH; Payzin S; Kültürsay H; Soydan I Anadolu Kardiyol Derg; 2002 Sep; 2(3):262-4. PubMed ID: 12223337 [No Abstract] [Full Text] [Related]
7. Revatio (sildenafil citrate) for the treatment of pulmonary arterial hypertension. Sahni J Conn Med; 2006; 70(6):381-3. PubMed ID: 16869470 [No Abstract] [Full Text] [Related]
8. Addition of prostanoids in pulmonary hypertension deteriorating on oral therapy. Jacobs W; Boonstra A; Marcus JT; Postmus PE; Vonk-Noordegraaf A J Heart Lung Transplant; 2009 Mar; 28(3):280-4. PubMed ID: 19285621 [TBL] [Abstract][Full Text] [Related]
9. Sildenafil for primary pulmonary hypertension: short and long-term symptomatic benefit. Jackson G; Chambers J Int J Clin Pract; 2002 Jun; 56(5):397-8. PubMed ID: 12137450 [TBL] [Abstract][Full Text] [Related]
10. Scheduled perioperative switch from oral sildenafil to intravenous epoprostenol in a patient with Eisenmenger syndrome undergoing a sigmoidectomy. Moriyama K; Uzawa K; Iijima T; Kotani M; Moriyama K; Ohashi Y; Satoh T; Yorozu T J Clin Anesth; 2012 Sep; 24(6):487-9. PubMed ID: 22762976 [TBL] [Abstract][Full Text] [Related]
11. Summaries for patients. A combination treatment for pulmonary hypertension. Ann Intern Med; 2008 Oct; 149(8):I-38. PubMed ID: 18936497 [No Abstract] [Full Text] [Related]
12. Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension. Stiebellehner L; Petkov V; Vonbank K; Funk G; Schenk P; Ziesche R; Block LH Chest; 2003 Apr; 123(4):1293-5. PubMed ID: 12684325 [TBL] [Abstract][Full Text] [Related]
13. Nebulized therapies for childhood pulmonary hypertension: an in vitro model. Katz SL; Adatia I; Louca E; Leung K; Humpl T; Reyes JT; Coates AL Pediatr Pulmonol; 2006 Jul; 41(7):666-73. PubMed ID: 16703580 [TBL] [Abstract][Full Text] [Related]